BSD Medical’s Hyperthermia Therapy (NASDAQ:BSDM)
Source: http://feedproxy.google.com/~r/FavStocks/~3/k6WuCSeGsYw/Posted on Friday, October 30th, 2009 | In Biotech, Investing Lessons, Stocks to Watch
BSD Medical Corporation (NASDAQ:BSDM) today announced that their published study results demonstrated improvement in the overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy delivered through BSD-2000 Hyperthermia System. This therapy was delivered as a standard treatment regimen for the 45 patients suffering from high-risk bladder cancer.
The multi-institutional study was named as Quadrimodal treatment of high risk T1 and T2 bladder cancer. The research was conducted by eight well-known medical researchers who are the front-runners in the field of oncology research. The study was conducted at three prestigious medical centers one being one of the largest universities in Germany, University of Erlangen, which provides an unique range of interdisciplinary research, and also at University of Frankfurt and Hospital Martha-Maria in Germany. The study was published in Radiotherapy and Oncology which is the official publication of the European Society for Therapeutic Radiology and Oncology.
One of the primary goals for the addition of hyperthermia to trimodal therapy is to optimize the survival rate while preserving the bladder function and study data reveals that the therapy is promising and will come out with positive response. In addition to this study, the researchers also revealed that previous clinical studies also showed promising results where 83 patients with intermediate or high-risk bladder tumors were randomized to receive this hyperthermia therapy and the percentage of tumor recurrence reduced by the addition of hyperthermia. BSD Medical is now trying to explore this therapy for further improvement. Currently, BSD Medical’s product line includes other systems that have been designed to offer a range of thermal treatment systems. The BSD-2000 Hyperthermia System is only for the investigational use in the United States.
Last 5 posts by Jay Garcilazo
- Echo Therapeutics Bullish on Recent News (OTC:ECTE) - November 20th, 2009
- CombinatoRx Neuromed Merger at risk? (NASDAQ:CRXX) - November 20th, 2009
- Power3 Investors Looking Forward to Expo (OTC:PWRM) - November 18th, 2009
- Power3 Investors Looking Forward to Expo (OTC:PWRM) - November 18th, 2009
- Bullish Technical Breakout Alert (OTC:SNBP) - November 17th, 2009
Biotech, Bladder Cancer, bladder tumors, BSD Medical Corporation, European Society for Therapeutic Radiology and Oncology, FavStocks, Germany, Investing Lessons, radiotherapy, Stocks to Watch, thermal treatment systems, tumor, United States, University of Erlangen, University of Frankfurt and Hospital Martha-Maria in Germany
 About Jay Garcilazo (http://favstocks.com)
I grew up in Boca Raton, Florida. After graduating high school I enrolled at Florida State University where I studied Journalism and Political Science. It was around this time that I got a job in the healthcare industry, a job that would give me a lot of experience as I worked and moved up over the next four and a half years. This along with working for a hedge fund manager for years, were the greatest learning experiences of my life so far. I have also been fortunate enough to have lived all over the country in, Austin, Texas, Queens, New York, Great Falls, Montana, Cleveland, Ohio, Chattanooga, Tennessee, Atlanta, Georgia, and all over the state of Florida. As well as living in many places I have traveled all over, been to all of the states except California (Had a layover at LAX once but I don’t think that counts), Oregon, and Hawaii. Traveled most of the Caribbean, I have also been to many destinations in Canada, and Mexico. I even did a stint through Europe. As well as traveling and living all over I have also worked in a great many industries. I have been employed in finance, healthcare, title, mortgage, travel, video game development, hospitality, and news industries. Besides working for an investment company I have also done quite a bit of investing on my own, and through trial and error, learning from mistakes, and watching the news very closely I have made some decent money for myself. |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.